Anpario (LON:ANP) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?

Anpario plc (LON:ANPGet Free Report)’s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of GBX 496.93 and traded as low as GBX 455. Anpario shares last traded at GBX 463.15, with a volume of 65,796 shares trading hands.

Analysts Set New Price Targets

A number of brokerages have commented on ANP. Shore Capital Group reissued a “house stock” rating on shares of Anpario in a research note on Monday, January 19th. Canaccord Genuity Group upped their target price on shares of Anpario from GBX 550 to GBX 570 and gave the company a “buy” rating in a research report on Thursday, January 22nd. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, Anpario currently has an average rating of “Buy” and a consensus price target of GBX 570.

Get Our Latest Stock Report on Anpario

Anpario Stock Down 3.0%

The company has a market cap of £74.35 million, a PE ratio of 14.76 and a beta of 0.92. The company’s 50 day moving average is GBX 519.84 and its 200 day moving average is GBX 496.83. The company has a current ratio of 4.32, a quick ratio of 5.16 and a debt-to-equity ratio of 0.22.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Featured Articles

Receive News & Ratings for Anpario Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anpario and related companies with MarketBeat.com's FREE daily email newsletter.